Home
Conditions
Schizophrenia

Clinical trial condition

Schizophrenia

Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.

2,318 public trials 177 recruiting studies

Refine in advanced search Browse all conditions

Schizophrenia trial results

Completed

Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail

NCT00618280

Conditions: Chemically-Induced Disorders, Mental Disorders, Schizophrenia, +3 more
Locations: Psychiatrische Klinik und Poliklinik der Heinrich-Heine-Universität Düsseldorf, North Rhine-Westphalia, Germany

Forschungszentrum Jülich GmbH Jülich, North Rhine-Westphalia, Germany

View Trial Details

Completed

Artemisinin to Reduce The Symptoms of Schizophrenia

NCT00753506

Conditions: Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
Locations: Sheppard Pratt Health System Towson, Maryland, United States

View Trial Details

Completed

An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia

NCT01309373

Conditions: Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
Locations: Not specified

View Trial Details

Completed

Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment

NCT00707382

Conditions: Behavior, Health Behavior, Mental Disorders, +5 more
Locations: Department of Clinical Pharmacology, Bispebjerg Hospital and Research Unit, Psychiatric Centre Bispebjerg Copenhagen, Denmark

View Trial Details

Completed

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

NCT01376076

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Forest Investigative Site 001 Glendale, California, United States

Forest Investigative Site 004 Long Beach, California, United States

Forest Investigative Site 002 Willingboro, New Jersey, United States

Forest Investigative Site 003 Houston, Texas, United States

View Trial Details

Completed

Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder

NCT00061802

Conditions: Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
Locations: San Diego, California, United States

Hoffman Est, Illinois, United States

Lake Charles, Louisiana, United States

Jackson, Mississippi, United States

View all 13 locations

View Trial Details

Completed

Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia

NCT00320489

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Escondido, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. National City, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orange, California, United States

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Diego, California, United States

View all 49 locations

View Trial Details

Completed

Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia

NCT01506765

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Not specified

View Trial Details

Completed

Treatment for First-Episode Schizophrenia

NCT00000374

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Hillside Hospital Glen Oaks, New York, United States

Bronx-Lebanon Hospital Center The Bronx, New York, United States

View Trial Details

Completed

Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia

NCT00299702

Conditions: Disease Attributes, Mental Disorders, Pathologic Processes, +5 more
Locations: Not specified

View Trial Details

Schizophrenia

Schizophrenia trial results

Related conditions